FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Strides Pharma Testosterone Gel 1% Recall

Testosterone Gel 1%, 5 grams, 30 Unit-dose Packets in a carton, Rx only, Distributed by…

Strides Pharma, Inc. · Chestnut Ridge, NY

Risk level
Class II
Reported by FDA
Apr 2, 2025
Recall ID
D-0294-2025
Check your lot numberHow we source this data

Summary

Strides Pharma recalled Testosterone Gel 1% starting Mar 5, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0294-2025 on Apr 2, 2025. Reason: Presence of foreign substance: Presence of Benzene. Status: Ongoing.

Why it was recalled

Presence of foreign substance: Presence of Benzene.

Product description

Testosterone Gel 1%, 5 grams, 30 Unit-dose Packets in a carton, Rx only, Distributed by: Strides Pharma Inc., East Brunswick, NJ, NDC 64380-152-02

Lot numbers, UPCs & expiration codes

Lot #: 5501103A, Exp Mar-25; 5501237A, 5501238A, Exp Apr-25; 5501278A, Exp May-25; 5501280A, 5501342A, Exp Jun-25; 5501372A, Exp Jul-25; 5501496A, Exp Aug-25; 5501499A, Exp Sep-25; 5501580A, Exp Oct-25; 5501582A, Exp Dec-25; 5501653A, 5501656A, Exp Jan-26; 5501770A, Exp Feb-26; 5501842A, 5501868A, 5501882A, Exp Apr-26; 5501957A, Exp May-26; 5502001A, Exp Jul-26; 5502033A, Exp Aug-26; 5502112A, 5502115A, Exp Oct-26; 5502180A, 5502181A, Exp Nov-26.

Where it was sold

Nationwide in the U.S

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0294-2025
Classification
Class II
Status
Ongoing
Recall initiated
Mar 5, 2025
FDA report date
Apr 2, 2025
Quantity
244,412 Cartons; 30 sachets /Carton
Recall type
Voluntary: Firm initiated
Recalling firm
Strides Pharma, Inc.

Original FDA data

Every field from FDA enforcement report D-0294-2025, exactly as published.

Show all FDA fields
City
Chestnut Ridge
State
NY
Status
Ongoing
Country
United States
Event ID
96412
Address
1 Ram Ridge Rd
Code information
Lot #: 5501103A, Exp Mar-25; 5501237A, 5501238A, Exp Apr-25; 5501278A, Exp May-25; 5501280A, 5501342A, Exp Jun-25; 5501372A, Exp Jul-25; 5501496A, Exp Aug-25; 5501499A, Exp Sep-25; 5501580A, Exp Oct-25; 5501582A, Exp Dec-25; 5501653A, 5501656A, Exp Jan-26; 5501770A, Exp Feb-26; 5501842A, 5501868A, 5501882A, Exp Apr-26; 5501957A, Exp May-26; 5502001A, Exp Jul-26; 5502033A, Exp Aug-26; 5502112A, 5502115A, Exp Oct-26; 5502180A, 5502181A, Exp Nov-26.
Postal code
10977-6714
Report date
Apr 2, 2025
Product type
Drugs
Recall number
D-0294-2025
Classification
Class II
Recalling firm
Strides Pharma, Inc.
Product quantity
244,412 Cartons; 30 sachets /Carton
Reason for recall
Presence of foreign substance: Presence of Benzene.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Testosterone Gel 1%, 5 grams, 30 Unit-dose Packets in a carton, Rx only, Distributed by: Strides Pharma Inc., East Brunswick, NJ, NDC 64380-152-02
Distribution pattern
Nationwide in the U.S
Recall initiation date
Mar 5, 2025
Initial firm notification
Letter
Center classification date
Mar 25, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0294-2025, published Apr 2, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls